Insight Trends

Generic Pharmaceuticals Market Trends, Growth and Impact of AI on Drug Development

Generic Pharmaceuticals Market Size, Companies and Innovations

The global generic pharmaceuticals market was valued at approximately $392.23 billion in 2023 and is expected to reach $947.67 billion by 2034, growing at a compound annual growth rate (CAGR) of 8.35% from 2024 to 2034.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5242

Major Key Insights of the Generic Pharmaceuticals Market

  • In 2023, North America led the global generic pharmaceuticals market, holding 36% of the market share.
  • The Asia-Pacific region is expected to be the fastest-growing market during the forecast period.
  • The simple generics segment was the largest in the market in 2023.
  • The biosimilars segment is projected to experience the fastest growth from 2024 to 2034.
  • Cardiovascular diseases accounted for the largest share of the global generic pharmaceuticals market in 2023.
  • The cancer segment is expected to grow at the highest rate in the coming years.
  • The small molecule segment dominated the market in 2023.
  • The large molecule segment is expected to see significant growth from 2023 to 2034.
  • Oral medications were the most common route of administration in 2023.
  • The injectable segment is predicted to see notable growth in the near future.
  • Retail pharmacies held the largest share of the distribution channels for generic pharmaceuticals in 2023.
  • The online pharmacy segment is expected to grow at the fastest rate during the forecast period.

Generic Pharmaceuticals Market Trends

  • Growing Demand for Affordable Medications: High prices of branded drugs make them unaffordable for many people in low- and middle-income countries (LMICs), driving the demand for more affordable generic medicines. This trend is helping to fuel market growth.
  • Increase in Off-Patent Drugs: A large number of drugs are set to lose their patents in the coming years, which is expected to drive the growth of the generic pharmaceuticals market as these medications become available in generic forms.
  • Supportive Regulatory Environment: The development and introduction of generic medicines are supported by favorable regulatory frameworks in many countries, making it easier for generics to be approved and launched in the market.

How AI Can Improve the Generic Pharmaceuticals Market

Artificial intelligence (AI) is transforming the pharmaceutical industry by introducing automation and modernization across various processes. In the generic pharmaceuticals market, AI can help researchers improve drug design, develop formulations, and make clinical trials more efficient and accurate. By speeding up these processes, AI can reduce the time it takes for generic drugs to reach the market. Predictive analytics and natural language processing (NLP) can assist in identifying compounds similar to those in branded drugs, helping to create generics more effectively. Machine learning algorithms can also assess the solubility of compounds, ensuring they maintain their effectiveness over time. Additionally, AI can help determine the crystal structure of a drug compound, which plays a key role in ensuring the drug’s manufacturing quality and stability, preventing it from breaking down and ensuring it remains effective.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/generic-pharmaceuticals-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5242

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Elena Morales

Elena Morales is a healthcare industry expert working at Healthcare Web Wire Consulting Firm, a subsidiary of Towards Healthcare. With her excellent knowledge of the field, Elena helps clients optimize their operations and navigate healthcare regulations. She's dedicated to staying updated on industry trends to make a positive impact on patient care. Elena is known for her professionalism and commitment to excellence, making her a valuable asset to any team.

Recent Posts

Kedrion Biopharma’s COAGADEX® Receives FDA Orphan Drug Designation for Acquired Factor X Deficiency (AFXD)

Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More

2 days ago

Benecard PBF and DecisionRX Join Forces to Personalize and Optimize Pharmacy Benefits

enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More

2 days ago

Four Resilient Biotech Companies Making Waves in a Challenging Market

In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More

2 days ago

Natera Launches TEODOR Trial in Partnership with ABCSG to Advance Personalized Breast Cancer Treatment

cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More

2 days ago

Interventional Radiology Market: Size, Growth, and Leading Companies Driving Innovation

The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More

2 days ago

Physical Therapy Market Growth and Leading Companies Driving Innovation

The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More

2 days ago